Key facts
| Price (PPV) | 4,205 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | fraction phospholipidique de poumon |
| Class | Other respiratory system products |
| ATC code | R07AA02 |
| Manufacturer | PROMOPHARM (HIKMA) |
| Presentation | Flacon de 1.5 ML |
| Nature | Médicament |
| Hospital price | 3,917 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement des nouveau-nés prématurés à haut risque de présenter ou présentant un syndrome de détresse respiratoire (SDR) par déficit en surfactant pulmonaire (maladie des membranes hyalines).
Find an open pharmacy
On-call pharmacies near you
About Curosurf 120 mg / 1.5 mg
Curosurf 120 mg / 1.5 mg belongs to the other respiratory system products therapeutic class. In Morocco, this drug is marketed by PROMOPHARM (HIKMA) and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Curosurf 120 mg / 1.5 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Curosurf 120 mg / 1.5 mg
Answers to common questions from Moroccan patients about this drug.